Change in the Annual Antibiotic Susceptibility of Escherichia coli in Community-Onset Urinary Tract Infection between 2008 and 2017 in a Tertiary Care Hospital in Korea
10.3346/jkms.2019.34.e228
- Author:
Young Jun KIM
1
;
Jeong Mi LEE
;
Jihyun CHO
;
JaeHoon LEE
Author Information
1. Department of Internal Medicine, Wonkwang University College of Medicine, Iksan, Korea. john7026@wku.ac.kr
- Publication Type:Brief Communication
- Keywords:
Urinary Tract Infection;
Escherichia coli;
Antibacterial Agents
- MeSH:
Amikacin;
Anti-Bacterial Agents;
Cefotaxime;
Delivery of Health Care;
Escherichia coli;
Escherichia;
Imipenem;
Incidence;
Korea;
Tertiary Healthcare;
Urinary Tract Infections;
Urinary Tract
- From:Journal of Korean Medical Science
2019;34(34):e228-
- CountryRepublic of Korea
- Language:English
-
Abstract:
The susceptibility of Escherichia coli from community onset urinary tract infection (UTI) was evaluated by dividing community onset UTI into the simple community acquired-UTI (CA-UTI) and healthcare associated UTI (HCA-UTI) groups for a period of 10 years. The susceptibility of E. coli to most antibiotics, except amikacin and imipenem, continued to decrease. In the CA-UTI group, the susceptibility to cefotaxime was 88% in 2015, but rapidly decreased to 79.3% in 2017. The susceptibility to cefepime and piperacillin-tazobactam were 88.8% and 90.5% in 2017, respectively. In the HCA-UTI group, the susceptibility to most antibiotics markedly decreased to less than 60% by 2017. The incidence of ESBL-producing E. coli increased to 23.3% in the CA-UTI group in 2017.
